1. Home
  2. IOVA vs GOOS Comparison

IOVA vs GOOS Comparison

Compare IOVA & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • GOOS
  • Stock Information
  • Founded
  • IOVA 2007
  • GOOS 1957
  • Country
  • IOVA United States
  • GOOS Canada
  • Employees
  • IOVA N/A
  • GOOS N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • GOOS
  • Sector
  • IOVA Health Care
  • GOOS
  • Exchange
  • IOVA Nasdaq
  • GOOS Nasdaq
  • Market Cap
  • IOVA 975.1M
  • GOOS 1.1B
  • IPO Year
  • IOVA N/A
  • GOOS 2017
  • Fundamental
  • Price
  • IOVA $2.68
  • GOOS $11.26
  • Analyst Decision
  • IOVA Buy
  • GOOS Sell
  • Analyst Count
  • IOVA 10
  • GOOS 4
  • Target Price
  • IOVA $12.22
  • GOOS $11.00
  • AVG Volume (30 Days)
  • IOVA 26.0M
  • GOOS 1.6M
  • Earning Date
  • IOVA 08-07-2025
  • GOOS 07-31-2025
  • Dividend Yield
  • IOVA N/A
  • GOOS N/A
  • EPS Growth
  • IOVA N/A
  • GOOS N/A
  • EPS
  • IOVA N/A
  • GOOS 0.35
  • Revenue
  • IOVA $212,679,000.00
  • GOOS $1,001,779,346.00
  • Revenue This Year
  • IOVA $86.62
  • GOOS $5.75
  • Revenue Next Year
  • IOVA $69.13
  • GOOS $4.84
  • P/E Ratio
  • IOVA N/A
  • GOOS $31.78
  • Revenue Growth
  • IOVA 11070.12
  • GOOS 2.32
  • 52 Week Low
  • IOVA $1.64
  • GOOS $6.73
  • 52 Week High
  • IOVA $12.51
  • GOOS $15.43
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 53.63
  • GOOS 36.25
  • Support Level
  • IOVA $1.70
  • GOOS $10.89
  • Resistance Level
  • IOVA $4.33
  • GOOS $15.43
  • Average True Range (ATR)
  • IOVA 0.40
  • GOOS 0.65
  • MACD
  • IOVA -0.01
  • GOOS -0.44
  • Stochastic Oscillator
  • IOVA 37.26
  • GOOS 8.26

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.

Share on Social Networks: